🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🗣️ Mark your calendars! 🧬 The international lecture series on chromosomal instability is coming to you soon. 🤓 Starting with superstar speaker Marcin Imieliński 🔥 May 17 on zoom.

now in nature: nature.com/articles/s4158… N&V: nature.com/articles/d4158…

thank you to all who stopped by my poster & helpful comments to improve the generative model! Memorial Sloan Kettering Cancer Center Tumor-Immune Systems Biology Symposium on 05-22-2024

An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, says a team led by Dr. Dan Landau (Dan Landau) and researchers at NY Genome Center and Memorial Sloan Kettering Cancer Center. bit.ly/45pXCJ3

BRCA1 and friends 30 years on -William D. Foulkes nature.com/articles/s4157… In this beautiful article in Nature Reviews Genetics , William Foulkes takes us back in time to the moment BRCA1 discovery was revealed to the world by Myriad Genetics at the ASHG 1994 (science.org/doi/10.1126/sc…).

With rheinbay_lab and additional Broad collaborators, we are excited to enter into this partnership with @Inocras to analyze whole genomes for the benefit of cancer research and cancer patients 🧬! Young Seok Ju @BroadInstitute Mass General Cancer Center

Applications are open for Max Planck Research Group Leaders! this is an amazing opportunity to build an independent research group that comes with 2.7 MEuro support over 6 years. If you're interested in being hosted Max-Planck-Institut für Astronomie, please contact me! mpg.de/career/max-pla…

אמא כותבת: איבדתי את הבן שלי שנהרג בעת שנלחם בגבורה בקרב בקיבוץ בארי. קצין צעיר רק בן 20. אני רק מבקשת שלא תשכחו את הילד הגיבור שלי!! אשמח שתשתפו לזכרו של הבן שלי יונתן גוטין גיבור ישראל!!

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab Nature Medicine Timothy Chan Nadeem Riaz nature.com/articles/s4159…

🚨 New preprint alert! We performed scRNA-seq & scTCR meta-analysis on cancer patients treated with ICIs, revealing key T cell signatures linked to therapeutic response, with insights into clonal replacement vs reinvigoration! #scRNAseq #Immunotherapy biorxiv.org/content/10.110…

Nobel for the not-junk-DNA! microRNA FTW! 😄😄😄

Cool scientists!

Most exciting event of spring 2025! Please come join us!

One way to trace AI over the last year is GPQA Diamond. This is a Google-proof question set that experts get 81% right in their fields & highly skilled non-experts with 30 minutes per question and Google access get 22%. GPT-4 got 37% at the start of 2024. o1 got 78%. o3 is 87.7%

We are hiring 🎺🎺🎺! As part of our immuno-oncology transformation Memorial Sloan Kettering Cancer Center we are building the Computational Immuno-Oncology Shared Resource. CIOSR is a key pillar supporting expanded immune monitoring & broad IO efforts. We have two open positions: bioinformatics

What a way to close out this year's APS March Meeting! #APSSummit25 #Aurora #Quantum

Tumor-Infiltrating Clonal Hematopoiesis nejm.org/doi/full/10.10…

Check out new work from NVIDIA Healthcare Genomics, Genentech, transcriptome-guided genomic alignment with transformer-based splice junction scoring, delivering SOTA in splice junction detection, indel identification, and resolving complex splicing patterns biorxiv.org/content/10.110…

1/ 🧵Check out our new study in Nature Genetics, which examines how precancerous conditions (MGUS/SMM) evolve into Multiple Myeloma, and offers new computational methods to predict progression risk and model cancer evolution. doi.org/10.1038/s41588…

Thrilled to share our paper now out in nature that correlates inactivating PPP2R1A somatic mutations with improved survival for patients with cancer receiving immunotherapy, with exciting prelim mechanistic insights! Amir Jazaeri Linghua Wang, MD, PhD Yibo nature.com/articles/s4158…